Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gasparini

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
European Heart Journal|June 4, 2002
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillationM Brignole, C Menozzi, M Gasparini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyF Crippa, G L Buraggi, E Di Re, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 28, 2001
Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial FibrillationM Brignole, L Gianfranchi, C Menozzi, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Circulation|November 14, 1997
Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled studyM Brignole, L Gianfranchi, C Menozzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
The clinical and ethical appropriateness of sedation in palliative neurological treatmentsV Bonito, A Caraceni, L Borghi, et al.
Tumori|March 1, 1997
Internal mammary chain lymphoscintigraphy (IML) and IML-guided internal mammary chain biopsy (GIMB) in breast cancerR Benti, A Bruno, M Glacomelli, et al.
Cancer Research|December 1, 1995
Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragmentM J Blend, H Hyun, M Kozloff, et al.
International Journal of Cancer|June 19, 1993
trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stagesM G Borrello, I Bongarzone, M A Pierotti, et al.
Journal of the American College of Cardiology|September 14, 1999
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversionA De Simone, G Stabile, D F Vitale, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
European Heart Journal|June 4, 2002
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillationM Brignole, C Menozzi, M Gasparini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyF Crippa, G L Buraggi, E Di Re, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 28, 2001
Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial FibrillationM Brignole, L Gianfranchi, C Menozzi, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Circulation|November 14, 1997
Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled studyM Brignole, L Gianfranchi, C Menozzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
The clinical and ethical appropriateness of sedation in palliative neurological treatmentsV Bonito, A Caraceni, L Borghi, et al.
Tumori|March 1, 1997
Internal mammary chain lymphoscintigraphy (IML) and IML-guided internal mammary chain biopsy (GIMB) in breast cancerR Benti, A Bruno, M Glacomelli, et al.
Cancer Research|December 1, 1995
Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragmentM J Blend, H Hyun, M Kozloff, et al.
International Journal of Cancer|June 19, 1993
trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stagesM G Borrello, I Bongarzone, M A Pierotti, et al.
Journal of the American College of Cardiology|September 14, 1999
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversionA De Simone, G Stabile, D F Vitale, et al.
Pageof 21